Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1089 blog entries.

March 2025

Techcyte Expands its AI-Powered Parasitology Suite with the Launch of Wet Mount Iodine Solution

2025-03-07T12:21:31+00:00

Techcyte, a leader in AI-powered digital diagnostics, today announced the launch of its wet mount iodine solution (for research use only in the U.S.), a much anticipated addition to its Fusion Parasitology Suite, which already includes trichrome and MAF solutions. This expansion supports Techcyte’s mission to enhance diagnostic accuracy and efficiency in fecal ova and parasite (O&P) detection.

Techcyte Expands its AI-Powered Parasitology Suite with the Launch of Wet Mount Iodine Solution2025-03-07T12:21:31+00:00

Aiforia Closes a Deal with a Regional Health Authority of Sardinia in Italy

2025-03-07T10:07:06+00:00

The regional health authority of Sardinia in Italy has selected Aiforia Technologies Plc as a partner for AI-assisted diagnostics. This collaboration involves utilizing Aiforia's clinical AI solutions to analyze biopsies from breast and prostate cancer patients.

Aiforia Closes a Deal with a Regional Health Authority of Sardinia in Italy2025-03-07T10:07:06+00:00

New AI Pipeline Enhances Tissue Quantification in Cerebral Aneurysm Analysis

2025-03-06T14:08:59+00:00

A new AI-based pipeline could reduce the time pathologists spend analyzing tissue ingrowth in cerebral aneurysm specimens, according to research presented by Ishaq Ansari of Caldwell University. The automated system achieves high accuracy while reducing the analysis time from days to minutes.

New AI Pipeline Enhances Tissue Quantification in Cerebral Aneurysm Analysis2025-03-06T14:08:59+00:00

Aiforia and Orion Extend Collaboration to Preclinical Study Evaluations

2025-03-06T08:57:31+00:00

Aiforia and Orion extend collaboration to preclinical study evaluations Aiforia and Orion, a Finnish pharmaceutical company, today announced the extension of their collaboration to include the use of Aiforia's software solution for preclinical study evaluations.

Aiforia and Orion Extend Collaboration to Preclinical Study Evaluations2025-03-06T08:57:31+00:00

Epredia Receives U.S. FDA 510(K) Clearance for the E1000 Dx™ Digital Pathology Solution Designed to Improve Laboratory Workflow in Cancer Diagnostics

2025-03-05T16:43:05+00:00

Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), today announced U.S. Food and Drug Administration (FDA) 510(K) clearance for its E1000 Dx Digital Pathology Solution (E1000 Dx). The E1000 Dx consists of a high-speed, automated, whole-slide imaging digital scanner with medical grade viewer and advanced image management and viewer software that creates high-resolution digital images of up to 1,500 tissue samples daily. This can allow laboratories to maximize throughput and streamline cancer diagnostics. With this clearance, Epredia adds clinical use to its portfolio of digital pathology technology, which has the potential to make diagnostics more efficient and accurate.

Epredia Receives U.S. FDA 510(K) Clearance for the E1000 Dx™ Digital Pathology Solution Designed to Improve Laboratory Workflow in Cancer Diagnostics2025-03-05T16:43:05+00:00

New Study Highlights the Role of Physical Color Calibration in Enhancing Digital Pathology Diagnostics by AI

2026-03-16T12:57:59+00:00

A new international study, supported by PathQA, has shown that physical color calibration can solve a key challenge in digital pathology AI: inconsistencies in whole slide images (WSIs) caused by different scanners. These variations potentially compromise diagnostic accuracy and reduce concordance with pathologists that limits widespread adoption, but this research demonstrates how PathQA’s Sierra ICC profiles can standardize scanner outputs and robustly improve reliability.

New Study Highlights the Role of Physical Color Calibration in Enhancing Digital Pathology Diagnostics by AI2026-03-16T12:57:59+00:00

Transforming Cancer Detection: Deep Bio’s AI Research Featured at USCAP Annual Meeting

2025-03-05T09:45:33+00:00

Deep Bio, a leader in AI-driven cancer diagnostics, is excited to announce its participation in the 114th United States and Canadian Academy of Pathology (USCAP) Annual Meeting, taking place from March 22 to March 27, 2025, at the Boston Convention and Exhibition Center. The company will showcase key research findings through one platform presentation and two poster sessions, highlighting Deep Bio’s advancements in using AI to enhance diagnostic accuracy and support pathologists in clinical decision-making.

Transforming Cancer Detection: Deep Bio’s AI Research Featured at USCAP Annual Meeting2025-03-05T09:45:33+00:00

Novel AI Framework Sidesteps Gleason Grading to Predict Prostate Cancer Outcomes

2025-03-05T08:00:00+00:00

Research from Lund University in Sweden showed that a new AI framework achieved high accuracy in predicting patient outcomes without relying on traditional Gleason grading methods. This approach extends beyond slide-level predictions to patient-level outcomes in the WSI setting.

Novel AI Framework Sidesteps Gleason Grading to Predict Prostate Cancer Outcomes2025-03-05T08:00:00+00:00

New AI-Powered Digital Pathology System Could Speed Up TP53 Testing in Leukemia

2025-03-04T09:33:12+00:00

For pathologists managing acute myeloid leukemia (AML), evaluating TP53 status often means choosing between time-consuming manual cell counting and expensive genetic testing. But that might be about to change, thanks to work from researchers at the University of Toronto.

New AI-Powered Digital Pathology System Could Speed Up TP53 Testing in Leukemia2025-03-04T09:33:12+00:00

Top 10 Great Things You’re Doing (and Should Be Doing) for Your Pathology & Oncology Software

2025-03-04T09:30:36+00:00

The pathology and oncology fields are rapidly evolving, presenting exciting opportunities for software development. Building successful solutions requires not just keeping up with technology but anticipating future needs. This article highlights ten key areas where leading developers are excelling, and where you should be focusing your efforts to create truly impactful software.

Top 10 Great Things You’re Doing (and Should Be Doing) for Your Pathology & Oncology Software2025-03-04T09:30:36+00:00
Go to Top